Obese Asthma Syndrome, Glucocorticoids, and Vitamin D: Mechanisms and Implications
The obese asthma syndrome (OAS) is characterized by increased airway inflammation and impaired lung function. Obesity-induced inflammation, characterized by elevated pro-inflammatory cytokines and reduced anti-inflammatory adipokines, contributes to airway inflammation and asthma symptoms. Asthmatic...
Main Authors: | Marina Bantulà, César Picado, Ebymar Arismendi |
---|---|
Format: | Article |
Language: | English |
Published: |
Publicaciones Permanyer
2023-04-01
|
Series: | Barcelona Respiratory Network Reviews |
Subjects: | |
Online Access: | https://www.brnreviews.com/frame_esp.php?id=232 |
Similar Items
-
Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation
by: Marina Bantulà, et al.
Published: (2021-01-01) -
Effects of Obesity and Asthma on Lung Function and Airway Dysanapsis in Adults and Children
by: Ebymar Arismendi, et al.
Published: (2020-11-01) -
Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss
by: Marina Bantulà, et al.
Published: (2022-06-01) -
Reference Gene Validation for RT–qPCR in PBMCs from Asthmatic Patients with or without Obesity
by: Marina Bantulà, et al.
Published: (2022-04-01) -
Gaps and Future Directions in Clinical Research on Obesity-Related Asthma
by: Andi C. Hudler, et al.
Published: (2023-06-01)